A patent waiver on COVID vaccines is right and fair.

Nature ; 593(7860): 478, 2021 05.

Article in En | MEDLINE | ID: mdl-34035532

Subject(s)

COVID-19 Vaccines/economics; COVID-19 Vaccines/supply & distribution; COVID-19/prevention & control; International Cooperation; Pandemics/prevention & control; Patents as Topic/legislation & jurisprudence; COVID-19/economics; COVID-19/epidemiology; China; Europe; Humans; India; Licensure/economics; Licensure/legislation & jurisprudence; Pandemics/economics; Pandemics/statistics & numerical data; Russia; South Africa; United Nations; United States; Vaccination/economics; Vaccination/statistics & numerical data; World Health Organization

Key words

Government; Intellectual-property rights; Policy; SARS-CoV-2; Vaccines

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patents as Topic / Pandemics / COVID-19 Vaccines / COVID-19 / International Cooperation Limits: Humans Country/Region as subject: Africa / America do norte / Asia / Europa Language: En Journal: Nature Year: 2021 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google